Prollenium Medical Technologies Announces Partnership Agreement with Ajanta Pharma to Market Revanesse(R) in India
9/17/2007 2:42:22 PM
RICHMOND HILL, ON, Sept. 17 /CNW/ - Ajanta Pharma has entered into an
in-licensing agreement with Prollenium Medical Technologies of Canada and will
have exclusive marketing rights for Prollenium's highly successful dermal
filler 'Revanesse(R)' in India.